Inhibitory effect of recombinant human CXCL8(3-72)K11R/G31P on atherosclerotic plaques in a mouse model of atherosclerosis

References

• Zhao LP, You T, Chan SP, et al. Adropin is associated with hyperhomocysteine and coronary atherosclerosis. Exp Ther Med. 2016;11:1065–1070.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340:115–126.
   PubMed Web of Science ®Google Scholar
• Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med. 2002;8:1257–1262.
   PubMed Web of Science ®Google Scholar
• Tan X, Zhang X, Pan L, et al. Identification of key pathways and genes in advanced coronary atherosclerosis using bioinformatics analysis. Biomed Res Int. 2017;2017:1.
   Google Scholar
• Hu D, Mohanta SK, Yin C, et al. Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin beta receptors. Immunity. 2015;42:1100–1115.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Z, Zhou M, et al. Therapeutic effects of fibroblast growth factor21 against atherosclerosis via the NFkappaB pathway. Mol Med Rep. 2018;17:1453–1460.
   PubMed Web of Science ®Google Scholar
• Sun L, Dou F, Chen J, et al. Salidroside slows the progression of EA.hy926 cell senescence by regulating the cell cycle in an atherosclerosis model. Mol Med Rep. 2018;17:257–263.
   PubMed Web of Science ®Google Scholar
• Sun LF, An DQ, Niyazi GL, et al. Effects of Tianxiangdan granule treatment on atherosclerosis via NF-κB and p38 MAPK signaling pathways. Mol Med Rep. 2018;17:1642–1650.
   PubMed Web of Science ®Google Scholar
• Simonini A, Moscucci M, Muller DW, et al. IL-8 is an angiogenic factor in human coronary atherectomy tissue. Circulation. 2000;101:1519–1526.
   PubMed Web of Science ®Google Scholar
• Martynowicz H, Janus A, Nowacki D, et al. The role of chemokines in hypertension. Adv Clin Exp Med. 2014;23:319–325.
   PubMed Web of Science ®Google Scholar
• Schroder JM, Christophers E. Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J Immunol. 1989;142:244–251.
   PubMed Web of Science ®Google Scholar
• Peveri P, Walz A, Dewald B, et al. A novel neutrophil-activating factor produced by human mononuclear phagocytes. J Exp Med. 1988;167:1547.
   PubMed Web of Science ®Google Scholar
• Boekholdt SM, Peters RJ, Hack CE, et al. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. ATVB. 2004;24:1503–1508.
   Google Scholar
• Aukrust P, Yndestad A, Smith C, et al. Chemokines in cardiovascular risk prediction. Thromb Haemost. 2007;97:748–754.
   PubMed Web of Science ®Google Scholar
• Herder C, Baumert J, Thorand B, et al. Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. ATVB. 2006;26:2147–2152.
   Google Scholar
• Chuntharapai A, Kim KJ. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor. J Immunol. 1995;155:2587–2594.
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Raimondo M, Woodward TA, et al. CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer. Int J Cancer. 2009;125:1027–1037.
   PubMed Web of Science ®Google Scholar
• Hertzer KM, Donald GW, Hines OJ. CXCR2: a target for pancreatic cancer treatment? Expert Opin Ther Targets. 2013;17:667–680.
   PubMed Web of Science ®Google Scholar
• Lisi S, Sisto M, Lofrumento DD, et al. GRO-alpha/CXCR2 system and ADAM17 correlated expression in Sjogren's syndrome. Inflammation. 2013;36:759–766.
   PubMed Web of Science ®Google Scholar
• Zhao X, Town JR, Li F, et al. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels. J Immunol. 2009;182:3213–3222.
   PubMed Web of Science ®Google Scholar
• Li F, Zhang X, Gordon JR. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8. Biochem Biophys Res Commun. 2002;293:939–944.
   PubMed Web of Science ®Google Scholar
• Zhao X, Town JR, Li F, et al. Blockade of neutrophil responses in aspiration pneumonia via ELR-CXC chemokine antagonism does not predispose to airway bacterial outgrowth. Pulm Pharmacol Ther. 2010;23:22–28.
   PubMed Web of Science ®Google Scholar
• Li F, Gordon JR. Il-8((3-73))K11R is a high affinity agonist of the neutrophil CXCR1 and CXCR2. Biochem Biophys Res Commun. 2001;286:595–600.
   PubMed Web of Science ®Google Scholar
• Khan MN, Wang B, Wei J, et al. CXCR1/2 antagonism with CXCL8/interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis. Oncotarget. 2015;6:21315–21327.
   PubMedGoogle Scholar
• Walana W, Ye Y, Li M, et al. IL-8 antagonist, CXCL8(3-72)K11R/G31P coupled with probiotic exhibit variably enhanced therapeutic potential in ameliorating ulcerative colitis. Biomed Pharmacother. 2018;103:253–261.
   PubMed Web of Science ®Google Scholar
• Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones. 2007;39:86–93.
   PubMedGoogle Scholar
• Wang L, Fan C, Topol SE, et al. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science. 2003;302:1578–1581.
   PubMed Web of Science ®Google Scholar
• Amorino GP, Hoover RL. Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. Am J Pathol. 1998;152:199–207.
   PubMed Web of Science ®Google Scholar
• Lin CP, Huang PH, Tsai HS, et al. Monascus purpureus-fermented rice inhibits tumor necrosis factor-alpha-induced upregulation of matrix metalloproteinase 2 and 9 in human aortic smooth muscle cells. J Pharm Pharmacol. 2011;63:1587–1594.
   PubMed Web of Science ®Google Scholar
• Wei L, Roberts W, Wang L, et al. Rho kinases play an obligatory role in vertebrate embryonic organogenesis. Development. 2001;128:2953–2962.
   PubMed Web of Science ®Google Scholar
• Berra-Romani R, Mazzocco-Spezzia A, Pulina MV, et al. Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol Cell Physiol. 2008;295:C779–C790.
   PubMed Web of Science ®Google Scholar
• Liu L, Liu Y, Liu C, et al. Analysis of gene expression profile identifies potential biomarkers for atherosclerosis. Mol Med Rep. 2016;14:3052–3058.
   PubMed Web of Science ®Google Scholar
• Qin Y, Fan F, Zhao Y, et al. Recombinant human CXCL8(3-72)K11R/G31P regulates smooth muscle cell proliferation and migration through blockage of interleukin-8 receptor. IUBMB Life. 2013;65:67–75.
   PubMed Web of Science ®Google Scholar
• Tucker WD, Mahajan K. Anatomy, blood vessels. Treasure Island (FL): StatPearls; 2019.
   Google Scholar
• Liu X, Peng J, Sun W, et al. G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice. Tohoku J Exp Med. 2012;228:147–156.
   PubMed Web of Science ®Google Scholar
• Hopkins PN. Molecular biology of atherosclerosis. Physiol Rev. 2013;93:1317–1542.
   PubMed Web of Science ®Google Scholar
• Gotsman I, Stabholz A, Planer D, et al. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associated with the severity of coronary artery disease: indicators of an active inflammatory burden? Isr Med Assoc J. 2008;10:494–498.
   PubMed Web of Science ®Google Scholar
• Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639–672.
   PubMed Web of Science ®Google Scholar